RPRX - Royalty Pharma plc

50
1.520   3.040%

Share volume: 3,034,663
Last Updated: 04-17-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.17%

PREVIOUS CLOSE
CHG
CHG%
$48.48
1.52
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
27%
Profitability 30%
Dept financing 16%
Liquidity 50%
Performance 22%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
3.24%
1 Month
9.19%
3 Months
27.91%
6 Months
36.50%
1 Year
55.33%
2 Year
79.28%
Key data
Stock price
$50.00
P/E Ratio 
28.93
DAY RANGE
$48.35 - $50.00
EPS 
$2.18
52 WEEK RANGE
$31.58 - $50.00
52 WEEK CHANGE
$55.33
MARKET CAP 
22.304 B
YIELD 
2.28%
SHARES OUTSTANDING 
576.857 M
DIVIDEND
$0.235
EX-DIVIDEND DATE
05-15-2026
NEXT EARNINGS DATE
08-07-2025
BETA 
-0.07
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$2,628,914
AVERAGE 30 VOLUME 
$3,109,710
Company detail
CEO: Pablo G. Legorreta
Region: US
Website: royaltypharma.com
Employees: 80
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Royalty Pharma plc was founded in 1996 and is based in New York, New York. Its portfolio consists of royalties on approximately 35 marketed therapies and 10 development-stage product candidates.

Recent news